新闻资讯

新闻资讯

current position: Home > News Center > Industry News

Sample Trial Production Process Norm & Flow

2026-05-10 03:22:15
times
Sample Trial Production Process Norm & Flow

Sample Trial Production Process Norm

Version: 1.0 | Effective Date: [YYYY-MM-DD] | Approved By: [Name/Department]

1. Purpose

To standardize the sample trial production process for new products, design modifications, or process optimizations. This norm ensures:

- Validation of product design feasibility.

- Verification of process parameters and equipment compatibility.

- Identification of quality risks and corrective actions before full-scale production.

- Compliance with industry standards (e.g., ISO 9001, FDA, IATF 16949) and internal quality requirements.

2. Scope

Applicable to all sample trial batches (small-scale production runs, typically 5–100 units) across manufacturing departments (e.g., injection molding, electronics assembly, chemical processing). Excludes lab-scale prototype development (covered under R&D SOPs).

3. Definitions

- Sample Trial Batch: A limited quantity of products produced to test design, process, or material performance.

- Critical Process Parameters (CPPs): Process variables that directly impact product quality (e.g., injection temperature, curing time).

- Critical Quality Attributes (CQAs): Product characteristics that must meet specifications (e.g., dimensional accuracy, tensile strength).

- Deviation: Any departure from the approved trial plan or standard operating procedures (SOPs).

4. Roles & Responsibilities

| Role/Department | Responsibilities |

|------------------|------------------|

| Project Manager | Coordinate cross-functional teams; approve trial plan; sign off on trial outcomes. |

| R&D Team | Provide design specs, material requirements, and technical guidance. |

| Production Team | Execute trial per plan; record process data; report deviations. |

| Quality Team | Inspect raw materials, in-process samples, and final products; validate test methods; issue quality reports. |

| Engineering Team | Calibrate equipment; troubleshoot process issues; optimize CPPs. |

5. Process Flow & Detailed Steps

5.1 Pre-Trial Preparation

1. Define Trial Objectives:

- Example: Validate injection molding parameters for a new plastic component; test material compatibility for a medical device.

2. Develop Trial Plan:

- Include: Batch size, process steps, equipment list, raw material specs, CPPs to monitor, CQAs to test, acceptance criteria, safety protocols.

3. Resource Preparation:

- Procure and inspect raw materials (verify lot numbers, specs).

- Calibrate equipment (e.g., temperature sensors, pressure gauges) and confirm availability.

- Train personnel on trial procedures, safety rules, and data recording.

4. Approval:

- Trial plan must be reviewed and approved by Project Manager, Quality Team, and R&D Lead.

5.2 Trial Execution

1. Initiation:

- Conduct a pre-trial briefing to confirm all teams are aligned.

2. Process Execution:

- Follow the trial plan strictly; record real-time data (CPPs, material usage, time stamps) in the Trial Data Log.

- Document all deviations (e.g., equipment malfunction, material defects) with root cause notes (if known).

3. Sample Collection:

- Collect representative samples at key stages:

- In-process: Mid-batch to check intermediate quality (e.g., mold fill, curing status).

- Final: Randomly select 10–20% of the batch for full CQA testing.

5.3 Post-Trial Activities

1. Quality Testing:

- Quality Team performs CQA tests (e.g., dimensional measurement, hardness, electrical performance) using validated methods.

- Generate a Quality Test Report with pass/fail results against specs.

2. Data Analysis:

- Cross-functional team reviews trial data and test results:

- Identify gaps between actual and target outcomes.

- Use root cause analysis tools (5 Whys, Fishbone Diagram) for deviations.

3. Outcome Decision:

- Approved: Trial meets all objectives → proceed to pilot production.

- Conditional Approval: Minor adjustments needed (e.g., tweak CPPs) → revise plan and re-trial.

- Rejected: Major design/process flaws → restart R&D phase.

4. Documentation:

- Compile all records into a Trial Summary Report (plan, data log, test report, deviation logs, outcome decision).

6. Quality Control & Inspection

- Incoming Materials: 100% inspection of raw materials against specs (e.g., material composition, purity).

- In-Process Inspection: Check CPPs at 15-minute intervals; reject batches if CPPs exceed tolerance.

- Final Inspection: Test CQAs per approved standards; only samples passing all tests are considered valid.

7. Documentation & Record Keeping

All records must be stored for at least 3 years (or longer per regulatory requirements):

- Trial Plan & Approval Form

- Raw Material Inspection Log

- Trial Data Log

- Deviation Report

- Quality Test Report

- Trial Summary Report

8. Risk Management

- Risk Identification: Prior to trial, list potential risks (e.g., equipment failure, material shortage) and mitigation measures (e.g., backup equipment, alternative materials).

- Risk Assessment: Use a risk matrix to prioritize risks (severity × likelihood) and assign owners.

9. Continuous Improvement

- Use trial data to update SOPs, optimize CPPs, and refine product design.

- Conduct quarterly reviews of trial outcomes to identify recurring issues and implement preventive actions.

10. Compliance & Audit

- All trial activities must adhere to regulatory standards (e.g., FDA 21 CFR Part 820 for medical devices).

- Internal audits will be conducted semi-annually to verify compliance with this norm.

---

Appendices:

- Appendix A: Trial Plan Template

- Appendix B: Trial Data Log Form

- Appendix C: Root Cause Analysis Guide

- Appendix D: Regulatory Compliance Checklist

---

This norm is subject to annual review and update by the Quality Management Department.

Recently Viewed:

  • menu

Contact Us

15950999188

Company Address

No.488 shannan West Road, Taicang, Suzhou, Jiangsu, China

official website
Copyright © Suzhou Qitai Textile Technology Co. All rights reserved record number:苏ICP备2023029896号 Disclaimer